Free Trial

Azenta (NASDAQ:AZTA) Shares Gap Down on Analyst Downgrade

Azenta logo with Medical background

Key Points

  • Azenta's stock price gapped down after Evercore ISI downgraded their price target from $35.00 to $33.00, resulting in an opening price of $30.38.
  • The company experienced a 15.8% decline in stock value, with recent trading at $29.57 and a market capitalization of $1.25 billion.
  • Institutional investors hold 99.08% of Azenta's stock, indicating strong interests from hedge funds and other entities despite the recent downgrade.
  • Want stock alerts on Azenta? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Azenta, Inc. (NASDAQ:AZTA - Get Free Report)'s stock price gapped down before the market opened on Tuesday after Evercore ISI lowered their price target on the stock from $35.00 to $33.00. The stock had previously closed at $32.41, but opened at $30.38. Evercore ISI currently has an in-line rating on the stock. Azenta shares last traded at $29.57, with a volume of 75,899 shares traded.

A number of other equities analysts have also recently issued reports on AZTA. Needham & Company LLC cut their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Stephens initiated coverage on shares of Azenta in a research report on Tuesday, July 22nd. They set an "equal weight" rating and a $35.00 target price for the company.

View Our Latest Research Report on AZTA

Institutional Investors Weigh In On Azenta

A number of hedge funds and other institutional investors have recently modified their holdings of AZTA. Headlands Technologies LLC purchased a new stake in Azenta in the fourth quarter valued at approximately $40,000. Mechanics Financial Corp grew its holdings in Azenta by 77.6% in the second quarter. Mechanics Financial Corp now owns 870 shares of the company's stock valued at $27,000 after purchasing an additional 380 shares during the period. Farther Finance Advisors LLC grew its holdings in Azenta by 788.1% in the first quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock valued at $33,000 after purchasing an additional 859 shares during the period. CWM LLC grew its holdings in Azenta by 113.5% in the second quarter. CWM LLC now owns 1,898 shares of the company's stock valued at $58,000 after purchasing an additional 1,009 shares during the period. Finally, Covestor Ltd grew its holdings in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after purchasing an additional 799 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Stock Down 15.8%

The business's fifty day moving average is $31.03 and its 200-day moving average is $34.91. The stock has a market capitalization of $1.25 billion, a PE ratio of -19.66 and a beta of 1.59.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.06. Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same quarter in the prior year, the company earned $0.14 earnings per share. The company's revenue was up .0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Company Profile

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines